Reproducibility of cytologic atypia in repeat nipple duct lavage

Cancer

Volumn 103, Issue 6, 2005, Pages 1129-1136

  Johnson Maddux, April ^a   Ashfaq, Raheela ^a   Cler, Leslie ^a   Naftalis, Elizabeth ^a   Leitch, Ann Marilyn ^a   Hoover, Susan ^a   Euhus, David M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Division of Hematology Oncology   (United States)

Author keywords

Breast neoplasms; Epithelial cells; Nipples; Precancerous conditions

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER RISK; CARCINOMA IN SITU; CYTODIAGNOSIS; DISEASE MARKER; EPITHELIUM CELL; FEMALE; HUMAN; LAVAGE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NIPPLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECANCER; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; RISK REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; CYTODIAGNOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRRIGATION; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NIPPLES; PRECANCEROUS CONDITIONS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 14744271089     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20884     Document Type: Article

References (21)

1. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol. 1992;135:130-141.
2. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst. 2001;93:1791-1798.
3. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000;92:1217-1227.
4. Dupont WD, Parl FF, Hartman WH, et al. Breast Cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258-1265.
5. Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
6. Port ER, Montgomery LL, Heerdt AS, Borgen PI. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol. 2001;8:580-585.
7. Morrow M, Vogel V, Ljung BM, O'Shaughnessy JA. Evaluation and management of the woman with an abnormal ductal lavage. J Am Coll Surg. 2002;194:648-656.
8. O'Shaughnessy JA, Ljung BM, Dooley WC, et al. Ductal lavage and the clinical management of women at high risk for breast carcinoma. Cancer. 2002;94:292-298.
9. Dooley WC, Ljung B, Veronesi U, et al. Ductal lavage for the detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001;93:1624-1632.
10. Brogi E, Robson M, Panageas KS, Casadio C, Ljung B-M, Montgomery L. Ductal lavage in patients undergoing mastectomy for mammary carcinoma. A correlative study. Cancer. 2003;98:2170-2176.
11. Hartman A-R, Daniel BL, Kurian AW, et al. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer. 2004;100:479-489.
12. Zera RT, Danielson D, Van Camp JM, et al. Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use. Surgery. 2001;130:732-737.
13. Tavassoli FA. The influence of endogenous and exogenous reproductive hormones on the mammary glands with emphasis on experimental studies in rhesus monkeys. Verh Dtsch Ges Pathol. 1997;81:514-520.
14. Harvell DM, Strecker TE, Tochacek M, et al. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA. 2000;97:2779-2784.
15. Mitchell G, Trott PA, Morris L, Coleman N, Sauter E, Eeles RA. Cellular characteristics of nipple aspiration fluid during the menstrual cycle in healthy premenopausal women. Cytopathology. 2001;12:184-196.
16. Going JJ, Moffat DF. Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol. 2004;203:538-544.
17. Johnson-Maddux A, Ashfaq R, Naftalis EZ, Leitch AM, Hoover S, Euhus DM. Patient and duct selection for nipple duct lavage. Am J Surg. 2004;188:390-394.
18. Evron E, Dooley WC, Umbricht CB, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet. 2001;357:1335-1336.
19. Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients. Breast Cancer Res Treat. 2004;84:99-105.
20. Yamamoto D, Senzaki H, Nakagawa H, Okugawa H, Gondo H, Tanaka K. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer. 2003;97:690-694.
21. King BL, Tsai SC, Gryga ME, et al. Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization. Clin Cancer Res. 2003;9:1509-1516.